• LDH Cytotoxicity Assay Kit: Practical Workflow

  2026-08-23

  The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive colorimetric approach for cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is appropriate for comparative cell damage quantification and cytotoxicity screening, but should not be used alone to identify apoptosis or another specific death mechanism.

• Fullerenols Target Ferroptosis in Cisplatin AKI

  2026-08-22

  This study identifies fullerenol nanoparticles as a potential ferroptosis-inhibitory strategy for cisplatin-induced acute kidney injury. Its key contribution is the integrated evidence that renal protection is associated with reduced lipid peroxidation and ferrous iron accumulation, together with preservation of the system Xc⁻/GSH/GPX4 antioxidant axis.

• Imatinib (STI571): PDGFR Assay Strategy

  2026-08-21

  Imatinib (STI571) is more than a BCR-ABL inhibitor: it is a practical probe for separating PDGFR, c-Kit, and Abl signaling in mechanistic assays. This article translates comparative pulmonary vascular remodeling research into an assay-first framework for cancer biology research and signal transduction studies.

• Bazedoxifene for Osteoporosis: Evidence and Limits

  2026-08-21

  The 2019 review evaluates Bazedoxifene as a third-generation selective estrogen receptor modulator for postmenopausal osteoporosis, emphasizing its vertebral fracture protection, modest lumbar-spine bone mineral density enhancement, and long-term tolerability. Its analysis also clarifies an important clinical boundary: benefits are not consistently demonstrated at the total hip or for nonvertebral fractures except in selected high-risk patients.

• Bestatin Dissects Arabidopsis Jasmonate Signaling

  2026-08-20

  The reference study established bestatin as a chemical-genetic probe for jasmonate signaling rather than merely an aminopeptidase inhibitor. By combining transcript profiling, hormone-response genetics, developmental phenotyping, and selection of bestatin-resistant Arabidopsis mutants, the authors identified distinct classes of regulators that separate COI1-dependent signaling from bestatin-specific responses.

• Camptothecin, DNA Damage, and Adaptive Evolution

  2026-08-20

  Camptothecin is more than a cytotoxic research reagent: it is a mechanistically defined topoisomerase I inhibitor for connecting DNA lesions, stress signaling, autophagy, and adaptive genome diversification. This article outlines translational workflows, experimental controls, competitive advantages, and the implications of recent prion-based mutagenesis research.

• Dye Models for Small Tissue Biopsies in Pathology

  2026-08-19

  The reference study evaluates five dyes as visibility aids for small tissue biopsies during routine surgical pathology processing. It identifies hematoxylin as the most practical candidate because it improved sample visibility while producing less toxicity and no reported interference during routine slide examination.

• Multi-Omics Maps ARID1A-Linked Melanoma Resistance

  2026-08-19

  The reference study integrates multi-omics and network analysis to define how ARID1A loss rewires early drug responses in BRAF-driven melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated nodes provides a framework for linking adaptive MAPK signaling, altered kinase activity, and immune-relevant changes.

• Losmapimod Workflows for p38 MAPK Research

  2026-08-18

  Losmapimod, also called GW856553X, supports controlled studies of p38α/β signaling across inflammation, endothelial biology, hypertension research, and COPD research. This practical guide combines solvent handling, time-resolved phospho-readouts, and a new dephosphorylation-focused assay strategy inspired by recent structural kinase research.

• Sphingosine-1-phosphate: Cell and Vascular Workflows

  2026-08-17

  Build more informative S1P experiments by pairing receptor-aware dose responses with endothelial, neuronal, and apoptosis readouts. This workflow uses fresh-solution handling, kinetic pathway sampling, and orthogonal validation to distinguish protective S1PR1 signaling from pro-apoptotic S1PR3 activity.

• VE-821: ATR Kinase Inhibitor Workflow Guide

  2026-08-17

  VE-821 provides a selective way to interrogate ATR–Chk1 checkpoint signaling in DNA repair pathway research, radiosensitization assays, and chemotherapy sensitization studies. This guide connects oncology workflows with a carefully bounded hypothesis for investigating ATR-dependent effects in human bocavirus 1 replication and RNA processing.

• Axitinib (AG 013736): From VEGFR Biology to Translation

  2026-08-16

  A mechanism-first guide to using Axitinib (AG 013736) in angiogenesis assays, cancer biology research, and xenograft translation—while separating target engagement, growth inhibition, and cell death.

• 2-APB for Calcium Signaling: Workflows & Troubleshooting

  2026-08-15

  2-APB provides a fast, cell-permeable way to interrogate IP3R-mediated calcium release and TRPC-linked channel activity. This guide translates its use into reproducible calcium imaging, SOCE, oxidative stress, and ischemia-reperfusion workflows while emphasizing dose-dependent interpretation and essential controls.

• Phenacetin as a Translational PK Benchmark

  2026-08-15

  Phenacetin can serve as a carefully controlled reference compound for pharmacokinetic studies, assay qualification, and translational exposure modeling. This thought-leadership article connects its physicochemical profile and safety history with lessons from PDK4 inhibitor discovery, while distinguishing benchmark value from therapeutic potential.

• BCECF for Mechanistic pH Assay Design

  2026-08-14

  BCECF provides a ratiometric route to extracellular and accessible-compartment pH measurement. This article shows how to use its signal as an assay-control layer when interpreting efferocytosis, ion transport, metabolism, and inflammatory microenvironment studies.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page